TY - JOUR
T1 - Somatic cell count as an indicator of subclinical mastitis and increased inflammatory response in asymptomatic lactating women
AU - Angelopoulou, Angeliki
AU - Harris, Hugh M.B.
AU - Warda, Alicja K.
AU - O'Shea, Carol Anne
AU - Lavelle, Aonghus
AU - Anthony Ryan, C.
AU - Dempsey, Eugene
AU - Stanton, Catherine
AU - Hill, Colin
AU - Paul Ross, R.
N1 - Publisher Copyright:
Copyright © 2024 Angelopoulou et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
PY - 2024/10
Y1 - 2024/10
N2 - Subclinical mastitis is an asymptomatic inflammatory condition that can be difficult to define and diagnose. In the dairy industry, subclinical mastitis is diagnosed by milk somatic cell counts (SCCs) of ≥250,000 cells mL−1. In this pilot study, we assessed the efficacy of this index to identify human subclinical mastitis by comparing SCC levels with the inflammatory response [interleukin-8 (IL-8) levels] in 37 samples from asymptomatic and 10 clinical mastitis (CM) lactating women. The milk microbiota was determined by 16S rRNA gene sequencing. The SCC of CM samples ranged from 310,000 to 6,600,000 cells mL−1. However, 14 of 37 (37.8%) asymptomatic samples had high SCC (250,000–460,000 cells mL−1), indicating subclinical mastitis. SCC levels significantly (P < 0.001) and positively correlated with milk IL-8 levels reflecting the escalating inflammatory response across subclinical and clinical mastitis samples. Samples with an SCC of ≥250,000 cells mL−1 showed significant increases in IL-8 responses when compared with milk samples from healthy women. The milk microbiome of CM samples was dominated by streptococcal and staphylococcal species (89.9% combined median relative abundance). In contrast, the combined median streptococcal/staphylococcal relative levels were 75.4% and 66.3% in milks from asymptomatic (subclinical mastitis) and healthy groups, respectively. The Streptococcus genus was increased in samples with an SCC of ≥250,000, although this should be interpreted with caution. Thus, the index of ≥250,000 somatic cells mL−1 could be a reliable indicator of subclinical mastitis in humans and should aid future studies investigating the impact of subclinical mastitis on maternal health, breastfeeding behaviors, infant health, and development. IMPORTANCE This pilot study suggests that SCC at a level of (greater than or equal to) 250,000 cells mL−1, as used in the dairy industry, is a suitable index to identify asymptomatic subclinical mastitis in lactating women since it reflects a significant increase in the inflammatory response compared to milk samples from healthy women. Using this index should aid studies into the short- and long-term consequences of subclinical mastitis for mother and infant.
AB - Subclinical mastitis is an asymptomatic inflammatory condition that can be difficult to define and diagnose. In the dairy industry, subclinical mastitis is diagnosed by milk somatic cell counts (SCCs) of ≥250,000 cells mL−1. In this pilot study, we assessed the efficacy of this index to identify human subclinical mastitis by comparing SCC levels with the inflammatory response [interleukin-8 (IL-8) levels] in 37 samples from asymptomatic and 10 clinical mastitis (CM) lactating women. The milk microbiota was determined by 16S rRNA gene sequencing. The SCC of CM samples ranged from 310,000 to 6,600,000 cells mL−1. However, 14 of 37 (37.8%) asymptomatic samples had high SCC (250,000–460,000 cells mL−1), indicating subclinical mastitis. SCC levels significantly (P < 0.001) and positively correlated with milk IL-8 levels reflecting the escalating inflammatory response across subclinical and clinical mastitis samples. Samples with an SCC of ≥250,000 cells mL−1 showed significant increases in IL-8 responses when compared with milk samples from healthy women. The milk microbiome of CM samples was dominated by streptococcal and staphylococcal species (89.9% combined median relative abundance). In contrast, the combined median streptococcal/staphylococcal relative levels were 75.4% and 66.3% in milks from asymptomatic (subclinical mastitis) and healthy groups, respectively. The Streptococcus genus was increased in samples with an SCC of ≥250,000, although this should be interpreted with caution. Thus, the index of ≥250,000 somatic cells mL−1 could be a reliable indicator of subclinical mastitis in humans and should aid future studies investigating the impact of subclinical mastitis on maternal health, breastfeeding behaviors, infant health, and development. IMPORTANCE This pilot study suggests that SCC at a level of (greater than or equal to) 250,000 cells mL−1, as used in the dairy industry, is a suitable index to identify asymptomatic subclinical mastitis in lactating women since it reflects a significant increase in the inflammatory response compared to milk samples from healthy women. Using this index should aid studies into the short- and long-term consequences of subclinical mastitis for mother and infant.
KW - breast milk
KW - breastfeeding
KW - clinical mastitis
KW - inflammation
KW - interleukin-8
KW - lactation
KW - milk microbiota
KW - somatic cell counts
KW - somatic cells
KW - subclinical mastitis
UR - https://www.scopus.com/pages/publications/85205740714
U2 - 10.1128/spectrum.04051-23
DO - 10.1128/spectrum.04051-23
M3 - Article
C2 - 39189754
AN - SCOPUS:85205740714
SN - 2165-0497
VL - 12
JO - Microbiology Spectrum
JF - Microbiology Spectrum
IS - 10
ER -